Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
Apply
HTR2 T Cells
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step